doi: 10.1097/fpc.0b013e32833947c2.
PharmGKB summary: very important pharmacogene information for CYP2B6
Affiliations
- PMID: 20648701
- PMCID: PMC3086041
- DOI: 10.1097/fpc.0b013e32833947c2
Item in Clipboard
PharmGKB summary: very important pharmacogene information for CYP2B6
Pharmacogenet Genomics.
2010 Aug.
No abstract available
Similar articles
-
Absence of CYP2B6 promoter -82T>C mutation in Chinese as an additional factor for slow metabolism of drugs commonly used in infections.Eur J Clin Pharmacol. 2006 Jul;62(7):585-6. doi: 10.1007/s00228-006-0163-6. Epub 2006 Jun 13. Eur J Clin Pharmacol. 2006. PMID: 16770645 No abstract available.
-
PCR-based haplotype determination to distinguish CYP2B6*1/*7 and *5/*6.Clin Chem. 2004 Aug;50(8):1472-3. doi: 10.1373/clinchem.2004.033233. Clin Chem. 2004. PMID: 15277362 No abstract available.
-
Detection of single nucleotide polymorphisms in CYP2B6 gene.Methods Enzymol. 2002;357:45-53. doi: 10.1016/s0076-6879(02)57664-3. Methods Enzymol. 2002. PMID: 12424896 No abstract available.
-
PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8.Pharmacogenet Genomics. 2013 Dec;23(12):721-8. doi: 10.1097/FPC.0b013e3283653b27. Pharmacogenet Genomics. 2013. PMID: 23962911 Free PMC article. Review. No abstract available.
-
Cytochrome P450 2B6: function, genetics, and clinical relevance.Drug Metabol Drug Interact. 2012;27(4):185-97. doi: 10.1515/dmdi-2012-0027. Drug Metabol Drug Interact. 2012. PMID: 23152403 Review.
Cited by
-
Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.Curr Pharmacogenomics Person Med. 2011 Sep;9(3):191-207. doi: 10.2174/187569211796957575. Curr Pharmacogenomics Person Med. 2011. PMID: 22563365 Free PMC article.
-
A Global Health Diagnostic for Personalized Medicine in Resource-Constrained World Settings: A Simple PCR-RFLP Method for Genotyping CYP2B6 g.15582C>T and Science and Policy Relevance for Optimal Use of Antiretroviral Drug Efavirenz.OMICS. 2015 Jun;19(6):332-8. doi: 10.1089/omi.2015.0039. OMICS. 2015. PMID: 26415139 Free PMC article.
-
Effects of Genetic Polymorphisms of Drug Transporter ABCB1 (MDR1) and Cytochrome P450 Enzymes CYP2A6, CYP2B6 on Nicotine Addiction and Smoking Cessation.Front Genet. 2020 Nov 30;11:571997. doi: 10.3389/fgene.2020.571997. eCollection 2020. Front Genet. 2020. PMID: 33329709 Free PMC article.
-
Role of Genetic Variations in the Hepatic Handling of Drugs.Int J Mol Sci. 2020 Apr 20;21(8):2884. doi: 10.3390/ijms21082884. Int J Mol Sci. 2020. PMID: 32326111 Free PMC article. Review.
-
Association between the CYP2B6 polymorphisms and nonnucleoside reverse transcriptase inhibitors drug-induced liver injury: a systematic review and meta-analysis.Sci Rep. 2024 Nov 27;14(1):29511. doi: 10.1038/s41598-024-79965-0. Sci Rep. 2024. PMID: 39604537 Free PMC article.
References
-
- Miksys S, Tyndale RF. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab Rev. 2004;36:313–333. - PubMed
-
- Zanger UM, Turpeinen M, Klein K, Schwab M. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem. 2008;392:1093–1108. - PubMed
-
- Code EL, Crespi CL, Penman BW, Gonzalez FJ, Chang TK, Waxman DJ. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Drug Metab Dispos. 1997;25:985–993. - PubMed
-
- Lang T, Klein K, Fischer J, Nussler AK, Neuhaus P, Hofmann U, et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics. 2001;11:399–415. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
